Combined Treatment With Sustained-Release Basic Fibroblast Growth Factor and Heparin Enhances Neovascularization in Hypercholesterolemic Mouse Hindlimb Ischemia-Reference-Cited by-同舟云学术

Combined Treatment With Sustained-Release Basic Fibroblast Growth Factor and Heparin Enhances Neovascularization in Hypercholesterolemic Mouse Hindlimb Ischemia

Published:2007 Issue:3 Volume:71 Page:412-417
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Arai Yoshio¹,Fujita Masatoshi²,Marui Akira¹,Hirose Keiichi¹,Sakaguchi Hisashi¹,Ikeda Tadashi¹,Tabata Yasuhiko³,Komeda Masashi¹

Affiliation:

1. Department of Cardiovascular Surgery, Kyoto University Graduate School of Medicine

2. School of Health Sciences, Faculty of Medicine, Kyoto University

3. Department of Biomaterials, Institute for Frontier Medical Sciences, Kyoto University

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://www.jstage.jst.go.jp/article/circj/71/3/71_3_412/_pdf

Reference37 articles.

1. Therapeutic Angiogenesis in Peripheral Arterial Disease: Can Biotechnology Produce an Effective Collateral Circulation?

2. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: Dose-response effect of basic fibroblast growth factor

3. Protein release from gelatin matrices

4. Tissue Regeneration Based on Growth Factor Release

5. Controlled and modulated release of basic fibroblast growth factor

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Crossroads between peripheral atherosclerosis, western-type diet and skeletal muscle pathophysiology: emphasis on apolipoprotein E deficiency and peripheral arterial disease;Journal of Biomedical Science;2017-07-08

2. Designing Acellular Injectable Biomaterial Therapeutics for Treating Myocardial Infarction and Peripheral Artery Disease;JACC: Basic to Translational Science;2017-04

3. Safety and efficacy of sustained release of basic fibroblast growth factor using gelatin hydrogel in patients with critical limb ischemia;Heart and Vessels;2015-04-11

4. Micro- and nanoparticles for treating cardiovascular disease;Biomaterials Science;2015

5. Scaffold biomaterials for nano-pathophysiology;Advanced Drug Delivery Reviews;2014-07